Vident Advisory’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179K Buy
12,505
+1,758
+16% +$29.2K ﹤0.01% 1730
2025
Q4
$190K Sell
10,747
-5,194
-33% -$85.9K ﹤0.01% 1564
2025
Q3
$251K Sell
15,941
-1,478
-8% -$20.8K ﹤0.01% 1478
2025
Q2
$194K Buy
17,419
+3,364
+24% +$39.4K ﹤0.01% 1513
2025
Q1
$164K Sell
14,055
-1,245
-8% -$16K ﹤0.01% 1469
2024
Q4
$209K Buy
+15,300
New +$222K ﹤0.01% 1331

Other funds holding SHC

Vident Advisory's SHC Position: Q1 2026 in Review

Vident Advisory increased its Sotera Health (SHC) stake by 16% in Q1 2026, buying an estimated $29.2K and bringing the position to 12,505 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1730.

Vident Advisory first reported a position in SHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $251K in Q3 2025. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Vident Advisory held 12,505 shares of Sotera Health worth $179K as of Q1 2026.
  • Vident Advisory bought 1,758 Sotera Health shares in Q1 2026, an estimated $29.2K.
  • Sotera Health made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1730 holding.
  • Vident Advisory first reported a position in Sotera Health in Q4 2024 and has held it in 6 quarters since.
  • Vident Advisory's Sotera Health position peaked at $251K in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.